RN specializing in NET's - Market Research Opinion Only!

We would like to invite you to take part in a research study that is being conducted by an independent research company, Community and Patient Preference Research (CaPPRe).

CaPPRe are experts in treatment preference research. They work closely with industry, academia, and government to encourage patient involvement and choice in healthcare decision-making. CaPPRe has been sponsored by a pharmaceutical company to investigate treatment preferences in the area of NETs.

Your participation is valuable in exploring what is important to nurses when it comes to different treatment options for NETs. You will receive payment through an electronic gift card in recognition of your time and contribution to this research.

The pharmaceutical company that is sponsoring this survey aims to publish the results in a peer-reviewed open-access medical journal. The publication will be freely accessible online to everyone. This study has been reviewed by an institutional ethics review board.
Who can participate?

We are looking for nurses who treat patients living with NETs in the US or Canada. Participants must have experience with long-acting somatostatin analogues (SSA) treatments.
What's involved?

Eligible participants will be asked to complete a 30 minute online survey.

IQVIA is a leading global provider of advanced analytics, technology solutions and clinical research services to the life sciences industry. We believe in pushing the boundaries of human science and data science to make the biggest impact possible - to help our customers create a healthier world. Learn more at https://jobs.iqvia.com

We are committed to providing equal employment opportunities for all, including veterans and candidates with disabilities. https://jobs.iqvia.com/eoe

As the COVID-19 virus continues to evolve, IQVIA's ability to operate and provide certain services to customers and partners necessitates IQVIA and its employees meet specific requirements regarding vaccination status. https://jobs.iqvia.com/covid-19-vaccine-status